|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, 667-675, April 2009 Phospholipids mediated conversion of HDLs generates specific apoA-II pre-β mobility particles
* Department of Laboratory Medicine, Medical University of Gda Published, JLR Papers in Press, December 9, 2008.
1 To whom correspondence should be addressed. e-mail: wroblew{at}amg.gda.pl Apolipoproteins (apo)A-I and A-II are major proteins of human HDL. The cycling of apoA-I between lipid-poor and lipid-rich forms of HDL plays a key role in the transport of cholesterol by these particles. ApoA-II resides only in part of HDL particles, and little is known about its role in HDL metabolism. Our study investigates the redistribution of apoA-II after HDL remodelling induced by exogenous phospholipids (PL). During incubation with egg yolk lecithin (EYL) liposomes, human HDL became PL-enriched and free cholesterol (FC)-depleted, and lost small amounts of apoA-I and apoA-II. The loss of FC and apolipoproteins correlated with the rise of PL content in HDL. Agarose gel electrophoresis demonstrated the appearance of new pre-β mobility fractions containing apoA-I and apoA-II in liposomes and HDL mixtures. Two-dimensional nondenaturing 2–27% PAGE has shown that the pre-β mobility fraction that appeared at initial liposome-PL/HDL-PL ratio 5:1 consisted of two distinct heterogeneous subpopulations of particles containing either apoA-I or apoA-II. Our study provides evidence that during HDL conversion mediated by PL apoA-II dissociated from HDL particles yielding apoA-II-specific pre-β mobility particles. This observation supports the hypothesis that apoA-II in plasma, like apoA-I, may cycle between lipid-poor and lipid-rich forms of HDL.
Supplementary key words apolipoprotein A-II high density lipoproteins A-II lipid-poor particles Abbreviations: apo, apolipoprotein; CE, cholesteryl esters; EYL, egg yolk lecithin; FC, free cholesterol; HDL A-I, HDL containing apoA-I without apoA-II; HDL A-I/A-II, HDL containing apoA-I and apoA-II; PL, phospholipids; TC, total cholesterol
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||